Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Liquid Biopsy"" wg kryterium: Temat


Tytuł:
Liquid Biopsy in Alzheimer's Disease Patients Reveals Epigenetic Changes in the PRLHR Gene.
Autorzy:
Macías M; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.
Acha B; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.
Corroza J; Neurology Department, Hospital Universitario de Navarra, IdiSNA, 31008 Pamplona, Spain.
Urdánoz-Casado A; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.
Roldan M; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.
Robles M; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.
Sánchez-Ruiz de Gordoa J; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.; Neurology Department, Hospital Universitario de Navarra, IdiSNA, 31008 Pamplona, Spain.
Erro ME; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.; Neurology Department, Hospital Universitario de Navarra, IdiSNA, 31008 Pamplona, Spain.
Jericó I; Neurology Department, Hospital Universitario de Navarra, IdiSNA, 31008 Pamplona, Spain.
Blanco-Luquin I; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.
Mendioroz M; Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.; Neurology Department, Hospital Universitario de Navarra, IdiSNA, 31008 Pamplona, Spain.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Nov 22; Vol. 12 (23). Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/genetics
Alzheimer Disease*/pathology
Cell-Free Nucleic Acids*
Epigenesis, Genetic*
Liquid Biopsy*
Humans ; DNA Methylation/genetics
Czasopismo naukowe
Tytuł:
Optical nanomaterial-based detection of biomarkers in liquid biopsy.
Autorzy:
Kim YJ; Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.
Rho WY; School of International Engineering and Science, Jeonbuk National University, Chonju, 54896, Republic of Korea.
Park SM; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, 637459, Singapore. .
Jun BH; Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2024 Mar 14; Vol. 17 (1), pp. 10. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
MicroRNAs*
Nanostructures*
Humans ; Biomarkers ; Liquid Biopsy ; Biopsy
Czasopismo naukowe
Tytuł:
Liquid Biopsy: A Game Changer for Type 2 Diabetes.
Autorzy:
Gradisteanu Pircalabioru G; eBio-Hub Research-Center, National University of Science and Technology 'Politehnica' Bucharest, 6 Iuliu Maniu Bulevard, Campus Building, 061344 Bucharest, Romania.; Research Institute of University of Bucharest, University of Bucharest, 050095 Bucharest, Romania.; Academy of Romanian Scientists, 3 Ilfov Str., 050094 Bucharest, Romania.
Musat M; eBio-Hub Research-Center, National University of Science and Technology 'Politehnica' Bucharest, 6 Iuliu Maniu Bulevard, Campus Building, 061344 Bucharest, Romania.; Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, 030167 Bucharest, Romania.; Department of Endocrinology, C.I. Parhon National Institute of Endocrinology, 011683 Bucharest, Romania.
Elian V; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, 5-7 Ion Movila Street, 030167 Bucharest, Romania.; Department of Diabetes, Nutrition and Metabolic Diseases, Prof. Dr. N. C. Paulescu National Institute of Diabetes, Nutrition and Metabolic Diseases, 030167 Bucharest, Romania.
Iliescu C; eBio-Hub Research-Center, National University of Science and Technology 'Politehnica' Bucharest, 6 Iuliu Maniu Bulevard, Campus Building, 061344 Bucharest, Romania.; Academy of Romanian Scientists, 3 Ilfov Str., 050094 Bucharest, Romania.; National Research and Development Institute in Microtechnologies-IMT Bucharest, 126A Erou Iancu Nicolae Street, 077190 Voluntari, Romania.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 25; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Mellitus, Type 2*/metabolism
Extracellular Vesicles*/metabolism
Cell-Free Nucleic Acids*/metabolism
Neoplastic Cells, Circulating*/pathology
Humans ; Biomarkers, Tumor/metabolism ; Liquid Biopsy/methods
Czasopismo naukowe
Tytuł:
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.
Autorzy:
Huang Z; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Fu Y; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Yang H; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Zhou Y; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Shi M; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Li Q; Genecast Biotechnology Co., Ltd, Wuxi, 214104, China.
Liu W; Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Liang J; Nanjing Geneseeq Technology Inc., Nanjing, 210032, Jiangsu, China.
Zhu L; Nanjing Geneseeq Technology Inc., Nanjing, 210032, Jiangsu, China.
Qin S; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. .
Hong H; Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. .
Liu Y; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Feb 17; Vol. 23 (1), pp. 36. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Epstein-Barr Virus Infections*
Lymphoma, T-Cell*/diagnosis
Lymphoma, T-Cell*/genetics
Humans ; Reproducibility of Results ; Biomarkers, Tumor/genetics ; Herpesvirus 4, Human ; Liquid Biopsy/methods
Czasopismo naukowe
Tytuł:
Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
Autorzy:
Yang H; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.; Guangdong Provincial Key Laboratory of Digestive Cancer Research, Shenzhen, Guangdong, China.
Xiao X; Guangdong Provincial Key Laboratory of Digestive Cancer Research, Shenzhen, Guangdong, China.
Zeng L; Department of Biobank, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.
Zeng H; Guangdong Provincial Key Laboratory of Digestive Cancer Research, Shenzhen, Guangdong, China.
Zheng Y; Clinical Big Data Research Center, Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
Wang J; Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Li G; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Dai W; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
He Y; Guangdong Provincial Key Laboratory of Digestive Cancer Research, Shenzhen, Guangdong, China.; Department of Gastrointestinal Surgery, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.
Wang S; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China. .
Peng J; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. .
Chen W; Guangdong Provincial Key Laboratory of Digestive Cancer Research, Shenzhen, Guangdong, China. .; Department of Gastrointestinal Surgery, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 03; Vol. 22 (1), pp. 132. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/diagnosis
Cell-Free Nucleic Acids*
Humans ; Phosphatidylinositol 3-Kinases/genetics ; Drug Evaluation, Preclinical ; Proto-Oncogene Proteins p21(ras)/genetics ; Early Detection of Cancer ; Liquid Biopsy ; Phosphoinositide-3 Kinase Inhibitors ; Biomarkers ; Class I Phosphatidylinositol 3-Kinases/genetics ; Mutation/genetics
Czasopismo naukowe
Tytuł:
Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review.
Autorzy:
Ramírez-Maldonado E; HBP Unit, General Surgery Department, Joan XXIII University Hospital, 43005 Tarragona, Spain.; Medicine and Surgery Department, Rovira i Virgili University, 43204 Reus, Spain.
López Gordo S; General Surgery Department, Maresme Health Consortium, 08304 Mataro, Spain.
Major Branco RP; General Surgery at Garcia de Orta's Hospital, 2805-267 Almada, Portugal.
Pavel MC; HBP Unit, General Surgery Department, Joan XXIII University Hospital, 43005 Tarragona, Spain.; Medicine and Surgery Department, Rovira i Virgili University, 43204 Reus, Spain.
Estalella L; HBP Unit, General Surgery Department, Joan XXIII University Hospital, 43005 Tarragona, Spain.; Medicine and Surgery Department, Rovira i Virgili University, 43204 Reus, Spain.
Llàcer-Millán E; HBP Unit, General Surgery Department, Joan XXIII University Hospital, 43005 Tarragona, Spain.; Medicine and Surgery Department, Rovira i Virgili University, 43204 Reus, Spain.
Guerrero MA; HBP Unit, General Surgery Department, Joan XXIII University Hospital, 43005 Tarragona, Spain.; Medicine and Surgery Department, Rovira i Virgili University, 43204 Reus, Spain.
López-Gordo E; Affinia Therapeutics Inc., Waltham, MA 02453, USA.
Memba R; HBP Unit, General Surgery Department, Joan XXIII University Hospital, 43005 Tarragona, Spain.; Medicine and Surgery Department, Rovira i Virgili University, 43204 Reus, Spain.
Jorba R; HBP Unit, General Surgery Department, Joan XXIII University Hospital, 43005 Tarragona, Spain.; Medicine and Surgery Department, Rovira i Virgili University, 43204 Reus, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 29; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/pathology
Neoplastic Cells, Circulating*/pathology
Humans ; Endothelial Cells/pathology ; Liquid Biopsy/methods ; DNA, Neoplasm/genetics ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes.
Autorzy:
Kim JJ; Department of Laboratory Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Kim HM; Department of Pathology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Kim H; Department of Laboratory Medicine, Chung-Ang University Gwangmyung Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
Kim SJ; Division of Hemato-Oncology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Lee ST; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Choi JR; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Shin S; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Hwang DY; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 314-323. Date of Electronic Publication: 2023 Jul 17.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Lymphoma*
Humans ; Liquid Biopsy ; Mutation ; Biomarkers, Tumor/genetics ; High-Throughput Nucleotide Sequencing
Czasopismo naukowe
Tytuł:
Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review.
Autorzy:
Seretis K; Department of Plastic Surgery, Medical School, University of Ioannina, 45100 Ioannina, Greece.
Boptsi E; Department of Plastic Surgery, Medical School, University of Ioannina, 45100 Ioannina, Greece.
Boptsi A; Department of Plastic Surgery, Medical School, University of Ioannina, 45100 Ioannina, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Extracellular Vesicles*/metabolism
Exosomes*/metabolism
Skin Neoplasms*/pathology
Humans ; Liquid Biopsy ; Biomarkers/metabolism
Czasopismo naukowe
Tytuł:
Protoporphyrin IX in serum of high-grade glioma patients: A novel target for disease monitoring via liquid biopsy.
Autorzy:
Walke A; Department of Neurosurgery, University Hospital of Münster, Albert-Schweitzer-Campus 1, A1, 48149, Münster, Germany. .; Core Unit Proteomics, Interdisciplinary Centre for Clinical Research, University of Münster, Münster, Germany. .
Krone C; Department of Neurosurgery, University Hospital of Münster, Albert-Schweitzer-Campus 1, A1, 48149, Münster, Germany.
Stummer W; Department of Neurosurgery, University Hospital of Münster, Albert-Schweitzer-Campus 1, A1, 48149, Münster, Germany.
König S; Core Unit Proteomics, Interdisciplinary Centre for Clinical Research, University of Münster, Münster, Germany.
Suero Molina E; Department of Neurosurgery, University Hospital of Münster, Albert-Schweitzer-Campus 1, A1, 48149, Münster, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 21; Vol. 14 (1), pp. 4297. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/pathology
Glioma*/pathology
Humans ; Photosensitizing Agents ; Neoplasm Recurrence, Local ; Aminolevulinic Acid ; Protoporphyrins ; Fluorescence ; Biomarkers ; Liquid Biopsy
Czasopismo naukowe
Tytuł:
Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises.
Autorzy:
Bandini S; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Ulivi P; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Rossi T; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 13; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplastic Cells, Circulating*/pathology
Extracellular Vesicles*/metabolism
Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Liquid Biopsy ; Biomarkers, Tumor/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Negative Charge-Carrying Glycans Attached to Exosomes as Novel Liquid Biopsy Marker.
Autorzy:
Kosutova N; Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 5807/9, 845 38 Bratislava, Slovakia.
Lorencova L; Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 5807/9, 845 38 Bratislava, Slovakia.
Hires M; Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 5807/9, 845 38 Bratislava, Slovakia.
Jane E; Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 5807/9, 845 38 Bratislava, Slovakia.
Orovcik L; Institute of Materials and Machine Mechanics, Slovak Academy of Sciences, Dubravska cesta 9/6319, 845 13 Bratislava, Slovakia.
Kollar J; Polymer Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 41 Bratislava, Slovakia.
Kozics K; Biomedical Research Centre, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
Gabelova A; Biomedical Research Centre, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
Ukraintsev E; Department of Physics, Faculty of Electrical Engineering, Czech Technical University in Prague, Technicka 2, 166 27 Prague, Czech Republic.
Rezek B; Department of Physics, Faculty of Electrical Engineering, Czech Technical University in Prague, Technicka 2, 166 27 Prague, Czech Republic.
Kasak P; Centre for Advanced Materials, Qatar University, Doha P.O. Box 2713, Qatar.
Cernocka H; Institute of Biophysics, Czech Academy of Sciences, Kralovopolska 135, 61200 Brno, Czech Republic.
Ostatna V; Institute of Biophysics, Czech Academy of Sciences, Kralovopolska 135, 61200 Brno, Czech Republic.
Blahutova J; Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 5807/9, 845 38 Bratislava, Slovakia.
Vikartovska A; Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 5807/9, 845 38 Bratislava, Slovakia.
Bertok T; Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 5807/9, 845 38 Bratislava, Slovakia.
Tkac J; Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 5807/9, 845 38 Bratislava, Slovakia.
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2024 Feb 08; Vol. 24 (4). Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Exosomes*/chemistry
Carcinoma*/metabolism
Carcinoma*/pathology
Male ; Humans ; Liquid Biopsy ; Lectins/analysis ; Lectins/metabolism ; Polysaccharides/analysis ; Polysaccharides/metabolism
Czasopismo naukowe
Tytuł:
Discrimination of pancreato-biliary cancer and pancreatitis patients by non-invasive liquid biopsy.
Autorzy:
Hartwig C; Innovation Field In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.; Institute for Interfacial Engineering and Plasma Technology IGVP, University of Stuttgart, Stuttgart, Germany.
Müller J; Innovation Field In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.; Center for Integrative Bioinformatics Vienna (CIBIV), Max Perutz Labs, University of Vienna and Medical University of Vienna, Vienna BioCenter, Vienna, Austria.; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria.
Klett H; Genedata GmbH, Munich, Germany.
Kouhestani D; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Mittelstädt A; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Anthuber A; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
David P; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Brunner M; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Jacobsen A; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Glanz K; Innovation Field In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.
Swierzy I; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Roßdeutsch L; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Klösch B; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Grützmann R; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.; Comprehensive Cancer Center, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
Wittenberger T; Genedata GmbH, Munich, Germany.
Sohn K; Innovation Field In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany. .
Weber GF; Department of Surgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany. .; Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany. .; Comprehensive Cancer Center, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany. .; Bavarian Cancer Research Center (BZKF), Erlangen, Germany. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Feb 02; Vol. 23 (1), pp. 28. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Pancreatic Intraductal Neoplasms*
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/pathology
Pancreatitis*/diagnosis
Pancreatitis*/genetics
Cell-Free Nucleic Acids*
Carcinoma, Pancreatic Ductal*/pathology
Humans ; Biomarkers, Tumor/genetics ; Liquid Biopsy
Raport
Tytuł:
Towards effectiveness of cell free DNA based liquid biopsy in head and neck squamous cell carcinoma.
Autorzy:
Kowal-Wisniewska E; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland. .; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland. .
Jaskiewicz K; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
Bartochowska A; Department of Otolaryngology and Laryngeal Oncology, Poznan University of Medical Sciences, Poznan, Poland.
Kiwerska K; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.; Department of Tumor Pathology, Greater Poland Cancer Centre, Poznan, Poland.
Ustaszewski A; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
Gorecki T; Faculty of Mathematics and Computer Science, Adam Mickiewicz University, Poznan, Poland.
Giefing M; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
Paluszczak J; Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Poznan, Poland.
Wierzbicka M; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.; Department of Otolaryngology and Laryngeal Oncology, Poznan University of Medical Sciences, Poznan, Poland.; Faculty of Medicine Wroclaw, University of Science and Technology, Wroclaw, Poland.
Jarmuz-Szymczak M; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 26; Vol. 14 (1), pp. 2251. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Cell-Free Nucleic Acids*/genetics
Head and Neck Neoplasms*/diagnosis
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/surgery
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/surgery ; Liquid Biopsy ; Specimen Handling ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies.
Autorzy:
Maansson CT; Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.; Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Thomsen LS; Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, Denmark.
Meldgaard P; Department of Oncology, Aarhus University Hospital, 8200 Aarhus, Denmark.
Nielsen AL; Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Sorensen BS; Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 19; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Cell-Free Nucleic Acids*
Lung Neoplasms*/genetics
Humans ; Liquid Biopsy ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection.
Autorzy:
Tumlinson AR; Twenty / Twenty Therapeutics LLC, South San Francisco, California, United States of America.
Calara JM; Twenty / Twenty Therapeutics LLC, South San Francisco, California, United States of America.
Azar DT; Twenty / Twenty Therapeutics LLC, South San Francisco, California, United States of America.
Adamis AP; Twenty / Twenty Therapeutics LLC, South San Francisco, California, United States of America.; Department of Ophthalmology, Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States of America.
Vavvas DG; Department of Ophthalmology, Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States of America.
Stewart JM; Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States of America.; Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 19; Vol. 19 (1), pp. e0294526. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Proteomics*
Insulins*/metabolism
Humans ; Infant, Newborn ; Intravitreal Injections ; Feasibility Studies ; Pilot Projects ; Vitreous Body/metabolism ; Biopsy ; Needles ; Liquid Biopsy
Czasopismo naukowe
Tytuł:
Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies.
Autorzy:
Martin-Alonso C; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Tabrizi S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA.
Xiong K; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Blewett T; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Sridhar S; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Crnjac A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Patel S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital, Boston, MA 02124, USA.
An Z; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Bekdemir A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Shea D; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Wang ST; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Rodriguez-Aponte S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Naranjo CA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Rhoades J; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Kirkpatrick JD; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Fleming HE; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Amini AP; Microsoft Research, Cambridge, MA 02142, USA.
Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Harvard Medical School, Boston, MA 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Love JC; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Bhatia SN; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.; Wyss Institute at Harvard University, Boston, MA 02215, USA.; Howard Hughes Medical Institute, Cambridge, MA 02138, USA.
Adalsteinsson VA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Jan 19; Vol. 383 (6680), pp. eadf2341. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Cell-Free Nucleic Acids*/blood
Neoplasms*/blood
Neoplasms*/diagnosis
Animals ; Mice ; Biomarkers, Tumor/blood ; Circulating Tumor DNA/blood ; Liquid Biopsy ; Mutation ; Humans ; Female ; Mice, Inbred BALB C ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Surpassing sensitivity limits in liquid biopsy.
Autorzy:
Moser T; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.; Christian Doppler Laboratory for Liquid Biopsies for Early Detection of Cancer, Medical University of Graz, Graz, Austria.
Heitzer E; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.; Christian Doppler Laboratory for Liquid Biopsies for Early Detection of Cancer, Medical University of Graz, Graz, Austria.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Jan 19; Vol. 383 (6680), pp. 260-261. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*/blood
Biomarkers, Tumor*/chemistry
Cell-Free Nucleic Acids*/blood
Cell-Free Nucleic Acids*/chemistry
Liquid Biopsy ; Humans ; Animals ; Mice ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Study of the ketohexokinase inhibitor PF-06835919 as a clinical cytochrome P450 3A inducer: Integrated use of oral midazolam and liquid biopsy.
Autorzy:
Qiu R; Pfizer Inc, Cambridge, Massachusetts, USA.
Fonseca K; Pfizer Inc, Cambridge, Massachusetts, USA.
Bergman A; Pfizer Inc, Cambridge, Massachusetts, USA.
Lin J; Pfizer Inc, Groton, Connecticut, USA.
Tess D; Pfizer Inc, Cambridge, Massachusetts, USA.
Newman L; Flinders University, Adelaide, South Australia, Australia.
Fahmy A; Flinders University, Adelaide, South Australia, Australia.
Useckaite Z; Flinders University, Adelaide, South Australia, Australia.
Rowland A; Flinders University, Adelaide, South Australia, Australia.
Vourvahis M; Pfizer Inc, New York, New York, USA.
Rodrigues D; Pfizer Inc, Groton, Connecticut, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2024 Jan; Vol. 17 (1), pp. e13644. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Midazolam*/pharmacokinetics
Cytochrome P-450 CYP3A*/metabolism
Humans ; Proteomics ; Pharmaceutical Preparations ; Liquid Biopsy ; Drug Interactions ; Administration, Oral
Czasopismo naukowe
Tytuł:
Exploring Optimal Biomarker Sources: A Comparative Analysis of Exosomes and Whole Plasma in Fasting and Non-Fasting Conditions for Liquid Biopsy Applications.
Autorzy:
Nasu M; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, 651 Ilalo Street, Honolulu, HI 96813, USA.
Khadka VS; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, 651 Ilalo Street, Honolulu, HI 96813, USA.
Jijiwa M; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, 651 Ilalo Street, Honolulu, HI 96813, USA.
Kobayashi K; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, 651 Ilalo Street, Honolulu, HI 96813, USA.
Deng Y; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, 651 Ilalo Street, Honolulu, HI 96813, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 27; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Exosomes*
MicroRNAs*/genetics
RNA, Small Untranslated*
Humans ; Hemolysis ; Fasting ; Biomarkers ; Liquid Biopsy
Czasopismo naukowe
Tytuł:
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.
Autorzy:
Zullo L; Dipartimento di Medicina Sperimentale (DIMES), Università Degli Studi di Genova, Via Leon Battista Alberti 2, 16132 Genova, Italy.; Departement de Medicine Oncologique, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France.
Dall'Olio FG; Departement de Medicine Oncologique, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France.
Rossi G; Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy.
Dellepiane C; Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy.
Barletta G; Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy.
Bennicelli E; Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy.
Ingaliso M; Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), Divisione di Anatomia Patologica, Università degli Studi di Genova, Largo Rosanna Benzi 10, 16132 Genova, Italy.
Tagliamento M; Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy.; Dipartimento di Medicina Interna e Specialità Mediche, Università Degli Studi di Genova, Viale Benedetto XV 6, 16132 Genova, Italy.
Genova C; Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy.; Dipartimento di Medicina Interna e Specialità Mediche, Università Degli Studi di Genova, Viale Benedetto XV 6, 16132 Genova, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 22; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lung Neoplasms*/genetics
Small Cell Lung Carcinoma*/genetics
Humans ; Liquid Biopsy ; Mutation ; PubMed
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies